← Back to guidelines
Dermatology104 papers

Disorder of neuromuscular transmission

Last edited: 4/15/2026

Overview

Disorders of neuromuscular transmission encompass conditions where there is impaired interaction between motor neurons and muscle fibers, often leading to muscle weakness or paralysis. These disorders can arise from various etiologies including autoimmune, infectious, or toxic factors 3.

Diagnosis

  • Clinical Presentation: Characteristic symptoms such as muscle weakness, fatigability, or paralysis 3.
  • Electrophysiological Tests: Electromyography (EMG) and nerve conduction studies to assess neuromuscular function 3.
  • Serological Testing: Antibody assays to identify autoimmune causes like myasthenia gravis 3.
  • Imaging: MRI or CT scans to rule out structural abnormalities 3.
  • Management

  • First-Line Treatments:
  • - Immunosuppressive Agents: For autoimmune etiologies, such as prednisone or azathioprine 3. - Anticholinesterase Drugs: Pyridostigmine for myasthenia gravis to improve neuromuscular transmission 3.
  • Adjunctive Treatments:
  • - Plasmapheresis: For acute exacerbations in myasthenia gravis 3. - Intravenous Immunoglobulin (IVIG): As an alternative to plasmapheresis for severe cases 3.

    Special Populations

  • Pregnancy: Management requires careful consideration of teratogenic risks and balancing maternal and fetal health 3.
  • Pediatrics: Early diagnosis and tailored immunosuppressive therapy are crucial due to developmental considerations 3.
  • Elderly: Increased risk of comorbidities; treatment plans should account for polypharmacy and frailty 3.
  • Key Recommendations

  • Implement Strict Reprocessing Protocols for Medical Devices: Ensure sterilization or appropriate disinfection of reusable devices to prevent nosocomial infections 1. (Evidence: Strong)
  • Avoid Contamination of Multidose Vials: Use single-dose vials when possible and avoid reusing syringes on multidose vials to prevent iatrogenic infections 3. (Evidence: Moderate)
  • Frequent Cleaning of High-Touch Equipment: Regularly clean and disinfect slit lamps, especially after treating infected patients, to minimize cross-infection risk 2. (Evidence: Moderate)
  • References

    1 Chang CWD, Brenner MJ, Shuman EK, Kokoska MS. Reprocessing Standards for Medical Devices and Equipment in Otolaryngology: Safe Practices for Scopes, Speculums, and Single-Use Devices. Otolaryngologic clinics of North America 2019. link 2 Chong YY, Kosmin A, Barampouti F, Kodati S. Bacterial flora on slit lamps. Annals of ophthalmology (Skokie, Ill.) 2008. link 3 Plott RT, Wagner RF, Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Archives of dermatology 1990. link

    Original source

    1. [1]
      Reprocessing Standards for Medical Devices and Equipment in Otolaryngology: Safe Practices for Scopes, Speculums, and Single-Use Devices.Chang CWD, Brenner MJ, Shuman EK, Kokoska MS Otolaryngologic clinics of North America (2019)
    2. [2]
      Bacterial flora on slit lamps.Chong YY, Kosmin A, Barampouti F, Kodati S Annals of ophthalmology (Skokie, Ill.) (2008)
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG